Healthcare >> CEO Interviews >> January 26, 2004

DAVID YOUNG – ARIUS RESEARCH INC (ARI:TSX.V)

DR. DAVID YOUNG is the President, Chief Scientific Officer and Chairman of ARIUS Research Inc. of Toronto, Ontario. ARIUS Research is a medical biotechnology company committed to the rapid discovery and development of functional cancer-killing antibodies. Dr. Young oversees general corporate strategy and directs the company's scientific programs. He received his Doctor of Medicine degree in 1990 and Master of Science degree through the Surgical Scientist Program in 1996, both from the University of Toronto. He did his surgical training at the University of Toronto. He is an author of more than 40 papers, abstracts and patents. From 1997 to 1999, he was a clinical associate in the Division of Cardiovascular Surgery at St. Michael's Hospital in Toronto. Profile
TWST: Would you begin with a brief historical sketch of ARIUS Research

and give us a picture of the things you're doing at the company at the

present time?

Dr. Young: ARIUS Research is a